Author:
Barrera-Ramirez Juliana,Lavoie Jessie R.,Maganti Harinad B.,Stanford William L.,Ito Caryn,Sabloff Mitchell,Brand Marjorie,Rosu-Myles Michael,Le Yevgeniya,Allan David S.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology
Reference27 articles.
1. Ayala, F., Dewar, R., Kieran, M., & Kalluri, R. (2009). Contribution of bone marrow microenvironment to leukemogenesis and leukemia progression. Leukemia, 23, 2233–2241.
2. Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009). Environment-mediated drug resistance: a major contributor to minimal residual disease. Nature Reviews. Cancer, 9, 665–674.
3. Roodhart, J. M. L., Daenen, L. G. M., Stigter, et al. (2011). Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell, 20, 370–383.
4. Ishikawa, F., Yoshida, Y., Saito, Y., et al. (2007). Chemotherapy-resistant human AML stem cells home to and engraft within the bone marrow endosteal region. Nature Biotechnology, 25, 1315–1321.
5. Hertenstein, B., Hambach, L., Bacigalupo, A., Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation, et al. (2005). Development of leukemia in donor cells after allogeneic stem cell transplantation—a survey of the European Group for Blood and Marrow Transplantation. Haematolgica, 90, 969–975.